SCHEMBL23010668

SCHEMBL23010668

CC(C)OP(O)(=S)OC[C@@H]1CCC(n2ccc(N)nc2=O)O1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLG P54098 2/20 0.49
POLB P06746 1/20 0.47
LMNA P02545 3/20 0.42
CACNA1F O60840 2/20 0.42
ALB P02768 2/20 0.42
MAPT P10636 2/20 0.42
CACNA1D Q01668 2/20 0.42
CACNA1S Q13698 2/20 0.42
CACNA1C Q13936 2/20 0.42
PDE3A Q14432 2/20 0.42
ST6GAL1 P15907 5/20 0.42
P2RY2 P41231 3/20 0.40
P2RY4 P51582 3/20 0.40
P2RY6 Q15077 2/20 0.40
POLA1 P09884 1/20 0.39
ABL1 P00519 1/20 0.38
RIN1 Q13671 1/20 0.38
THRB P10828 1/20 0.37
MTOR P42345 1/20 0.37
MDM2 Q00987 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18102346 0.89 POLG (0.54) POLGPOLBLMNACACNA1FALB
SCHEMBL6913592 0.87 POLG (0.49) POLGPOLBLMNACACNA1FALB
SCHEMBL1763274 0.84 POLG (0.59) POLGPOLBLMNACACNA1FALB
SCHEMBL21895844 0.84 POLG (0.55) POLGPOLBLMNACACNA1FALB
SCHEMBL23157013 0.84 POLG (0.55) POLGPOLBLMNACACNA1FALB
SCHEMBL23157216 0.84 POLG (0.55) POLGPOLBLMNACACNA1FALB
SCHEMBL454264 0.84 POLG (0.55) POLGPOLBLMNACACNA1FALB
SCHEMBL24229283 0.82 LMNA (0.46) POLGPOLBLMNACACNA1FALB
SCHEMBL26795253 0.82 LMNA (0.46) POLGPOLBLMNACACNA1FALB
SCHEMBL15257625 0.82 LMNA (0.46) POLGPOLBLMNACACNA1FALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2935303-B1 4'-FLUORO-NUCLEOSIDES, 4'-FLUORO-NUCLEOTIDES AND ANALOGS THEREOF FOR THE TREATMENT OF HCV JANSSEN BIOPHARMA INC (US) 2021-02-17 EP disclosed